Background and Significance:
Corneal epithelium is a moldable 1 and active corneal layer that keeps the optical quality of the eye by remodeling itself to compensate for any change in the stromal surface shape e.g. after keratorefractive surgery 2, 3 or in keratoconus 2, 4--6 . Mapping of the corneal epithelial thickness may help detect stromal surface irregularities like subclinical cones, before they become detectable on topography 2, 4, 6 . Mapping of the corneal epithelium has been previously attempted by use of various technologies such as ultrasound, confocal microscopy 2, 4, 7 and Optical coherence tomography (OCT) 1, 3, 5, 8, 9 . OCT has been developed for non--contact, cross--sectional imaging in biological systems by using low--coherence interferometry to produce a two--dimensional image of optical scattering from internal tissue microstructures in a way that is analogous to ultrasonic pulse--echo imaging 10 . Spectral domain (SD), a newer generation OCT to be used in the current study, seems to be reliable and reproducible 3, 9 in measuring corneal epithelial thickness in contrast to the measurements with the time domain OCT 11 and does not require immersion like very--high--frequency digital--ultrasound, which is the only method providing sufficient resolution for corneal epithelial imaging 2, 4, 12--14 . A recently published study utilizing the SD--OCT technology 8 compares the epithelial thickness distribution of keratoconic corneas with the corneas of healthy subjects with unspecified amount of astigmatism, while the current study will use healthy corneas with > 2D of astigmatism as the control group.
Purpose of the study:
To characterize epithelial and stromal thickness distribution in keratoconic eyes and to develop epithelial and stromal thickness-based variables for keratoconus detection.
Methodology:
SD-OCT scans of 20 eyes with keratoconus (group one) and twenty healthy eyes with > 2 diopters (D) of corneal astigmatism as controls (group two) will be analyzed. Two cross-sectional meridional corneal profiles (along steepest and flattest meridians, located by a Scheimpflug-based corneal topography) for each individual will be obtained by using a RTVue100 (Optovue Inc. Fremont, California, USA), 26000-Hz SD-OCT across the central 6mm diameter of the cornea.
To map the epithelial and stromal thickness distribution in eyes from group one, 11 locations will be measured: corneal vertex, cone apex, mid-peripheral cornea (1.5mm from corneal vertex) and peripheral cornea (2.5mm from corneal vertex) along both the steepest and flattest meridian, and the locations with thickest epithelium along the steepest meridian. In eyes from group two, 11 corresponding locations will be measured.
Inclusion /Exclusion Criteria
SD-OCT scans of 20 confirmed cases of keratoconus referred to CXL treatment at the University Hospital North Norway and 20 healthy subjects seeking refractive surgery at SynsLaser Kirurgi AS in Tromsø for astigmatism >2 D will be used. The participants will be the subjects to the inclusion/exclusion criteria by the two institutions, regarding keratoconus and candidacy for refractive surgery, respectively.
Study Schedule:
SD-OCT scans obtained from May 1, 2013 through August 31, 2013 will be analyzed.
Statistical Analysis Plan:
Statistical analysis will be performed using SPSS 13.0 software. The independentsamples t test will be used to assess the difference of epithelial and stromal thickness at corresponding locations between two groups and between different locations within group.
Descriptive statistics will be carried out for all eyes using vertical mirrored symmetry superimposition: thickness values for left eyes will be reflected in the vertical axis and superimposed onto the right eye values so that nasal/temporal characteristics could be combined.
The sample size was decided by the power calculation founded on data from the previous studies analyzing corneal epithelial thickness in keratoconus and healthy eyes. For a significance level of 0.05 and a statistical power of 0.8, the equation for sample size is: N=31.4xσ 2 /D 2 , where σ is assumed standard distribution of each group and D is the minimum expected difference between two means. According to the preliminary data collected from comparable studies 4 , population σ and D are chosen to be 5.0 and 4.7 respectively, yielding a sample size N=35.5. In the current study we chose a sample size 40.
Informed Consent Process:
The research will comply with the tenets of the Declaration of Helsinki. Informed consent will be obtained ahead of the examination. Invitation to participate in the scientific study and informed consent (both written in Norwegian) will be sent to prospective study participants in the letter of notifications for the scheduled visits to the Eye Dpt. UNN and to the SynsLaser Kirurgi AS in Tromsø, respectively. Privacy and confidentiality: Participant's names will be kept on a passwordprotected database, and will be linked only with a study identification number for this research. All the research data will be entered into a computer that is password protected and will be stored in a locked office of the investigators.
Risk/Benefit

Risk to participants
The participants in the project will be recruited either among the patients with keratoconus referred to the Eye Department, UNN for general or pre-CXL evaluation, or among the candidates seeking refractive surgery at the SysnLaser Kirurgi AS in Tromsø. The current study will not interfere with, or add any extra examinations to the participants´ already planned diagnostic/treatment procedures, thus it will not bring any extra risks to the participants.
Benefits to participants
The study will lead to better pre-corneal refractive surgery candidacy screening and potentially better postoperative result, and it may lead to earlier diagnosis of keratoconus.
